Loading...
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
Carcinoma of the prostate is the most commonly diagnosed cancer in men. The current pharmacological treatment of choice for progressive androgen-dependent prostate cancer is the nonsteroidal antiandrogen, bicalutamide, either as monotherapy or with adjuvant castration or luteinizing hormone-releasin...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2005
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1087923/ https://ncbi.nlm.nih.gov/pubmed/15833816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0500381102 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|